Duncan Jodrell is the Professor of Cancer Therapeutics at the University of Cambridge, the Director of the Cambridge Cancer Trials Centre and the co-Lead for Experimental Cancer Medicine at the CRUK Cambridge Centre.   Duncan moved to Cambridge from Edinburgh in 2008, establishing and leading an Early Phase clinical trials’ team.  He has a special interest in novel therapeutic approaches for the treatment of patients with pancreatic cancer.

A Medical Oncologist (an honorary consultant at Cambridge University Hospitals NHS Trust), Duncan completed his doctoral thesis at the Institute of Cancer Research and an MSc in Biochemistry at King’s College (University of London), post-doctoral research at the University of Maryland (Baltimore) and completed his clinical training at the Royal Marsden Hospital (London) and Beatson Oncology Centre (Glasgow).  Duncan has acted as the Chief or Principal Investigator in many Early Phase and Experimental Medicine studies, in addition to leading innovative laboratory research.